Octagon Capital Advisors »

Miragen Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 620k 21.78
2023-09-30 $16M 1.1M 15.34
2023-06-30 $22M 923k 23.79
2023-03-31 $30M 1.2M 25.44
2022-12-31 $24M 824k 29.21